# VitalScan MCG Rule-out Multi-centre Pivotal Study - US

> **NCT03546933** · — · TERMINATED · sponsor: **Creavo Medical Technologies Ltd** · enrollment: 651 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DEVICE:** VitalScan Magnetocardiograph

## Key facts

- **NCT ID:** NCT03546933
- **Lead sponsor:** Creavo Medical Technologies Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2018-07-17
- **Primary completion:** 2019-08-06
- **Final completion:** 2019-08-06
- **Target enrollment:** 651 (ACTUAL)
- **Why stopped:** A correction needs to be made to the device's algorithm.
- **Last updated:** 2019-09-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03546933

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03546933, "VitalScan MCG Rule-out Multi-centre Pivotal Study - US". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT03546933. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*